A critical advance in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer protector protein is frequently inactivated in several forms of cancer, causing https://socialstrategie.com/story7742954/vhh-fragments-reactivate-tumor-suppressor-p53-a-new-pathway-for-malignant-treatment